Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial
- DOI
- 10.1186/s13104-023-06281-7
- Published
- 2023-02-28
- Container
- BMC Research Notes
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13104-023-06281-7,
title = {Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial},
author = {Alejandro Llanos-Cuentas and Alvaro Schwalb and Juan Luis Quintana and Brian Delfin and Fiorela Alvarez and César Ugarte-Gil and Rosio I. Guerra Gronerth and Aldo Lucchetti and Max Grogl and Eduardo Gotuzzo},
year = {2023},
journal = {BMC Research Notes},
doi = {10.1186/s13104-023-06281-7},
url = {https://doi.org/10.1186/s13104-023-06281-7}
}RIS
TY - JOUR TI - Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial AU - Alejandro Llanos-Cuentas AU - Alvaro Schwalb AU - Juan Luis Quintana AU - Brian Delfin AU - Fiorela Alvarez AU - César Ugarte-Gil AU - Rosio I. Guerra Gronerth AU - Aldo Lucchetti AU - Max Grogl AU - Eduardo Gotuzzo PY - 2023 JO - BMC Research Notes DO - 10.1186/s13104-023-06281-7 UR - https://doi.org/10.1186/s13104-023-06281-7 ER -
APA
Llanos-Cuentas, A., Schwalb, A., Quintana, J. L., Delfin, B., Alvarez, F., Ugarte-Gil, C., Gronerth, R. I. G., Lucchetti, A., Grogl, M., & Gotuzzo, E. (2023). Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial. BMC Research Notes. https://doi.org/10.1186/s13104-023-06281-7
Source records
- crossref · retrieved 2026-09-26T23:15:52.557Z